Product information

Current status:

Cancelled Pre Market

Product name:

THALLIUM, THALLOUS CHLORIDE TI201

DIN:

Not Applicable Electronic product monograph is not available

Company:

BRISTOL-MYERS SQUIBB CANADA
2344 Boul. Alfred-Nobel, Suite 300
St-Laurent
Quebec
Canada H4S 0A4

Class:

Radiopharmaceutical

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Schedule C

American Hospital Formulary Service (AHFS): ^{See footnote 3}

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

Active ingredient group (AIG) number:^{See footnote5}

0152598003